During CKD, a secondary hyperparathyroidism occurs in which PTH is excessively secreted, in response to factors such as hyperphosphatemia, hypocalcemia, and low 1,25D levels, to potentially promote elevated FGF23 (74). Here, FGF23 is linked to hyperphosphatemia.